Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 3Renal Insufficiency, Chronic 2Prostatic Neoplasms 2Uterine Prolapse 1Urologic Neoplasms 1Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Neutropenia 1Neuromuscular Blockade 1Muscle Hypotonia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Melanoma 1Lung Neoplasms 1Leiomyoma 1Intraabdominal Infections 1Intestinal Obstruction 1

Interventions

Gemcitabine 9pembrolizumab 7Cisplatin 5enfortumab vedotin 4atezolizumab 4Trastuzumab 4Mitomycin 4Carboplatin 4Sunitinib 3Pemetrexed 3dodecyl maltoside 2cabozantinib 2Water 2Sugammadex 2Standard of Care 2Saline Solution 2Paclitaxel 2Nivolumab 2Neostigmine 2Docetaxel 2Cetuximab 2Bevacizumab 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1vinflunine 1valrubicin 1tucatinib 1tislelizumab 1testosterone 17 beta-cypionate 1temsirolimus 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Rocuronium × Clear all
NCT03138967 2020-09-22

Investigation of Sugammadex in Outpatient Urological Procedures

M.D. Anderson Cancer Center

Phase 4 Completed
54 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡